Drug Development

Nov 09, 2018
By BioPharm International Editors
More—and earlier—interaction between R&D and payers will be essential if innovative therapies are to become more accessible for patients, and more profitable for manufacturers, said panelists at the 2018 Galien Foundation Forum.
Nov 08, 2018
By BioPharm International Editors
The decision follows an FDA request for additional information to complement the company’s submission for biosimilar rituximab.
Nov 07, 2018
By BioPharm International Editors
The multi-year collaboration will incorporate NextCure's proprietary FIND-IO platform, a technology designed to identify novel cell-surface molecular interactions that drive functional immune responses in the tumor microenvironment and other disease sites.
Nov 01, 2018
BioPharm International
Survey results and record attendance may show positive signs for established and emerging biopharma regions.
Nov 01, 2018
By BioPharm International Editors
New data highlights ability of the SQZ cell therapy platform to preserve cellular functions.
Nov 01, 2018
By BioPharm International Editors
This new partnership provides access to Distributed Bio’s antibody discovery platforms.
Nov 01, 2018
By BioPharm International Editors
Thermo Fisher Scientific has entered into a collaboration with Symphogen to deliver validated, platform workflows for simplified characterisation and quality monitoring of complex therapeutic proteins.
Oct 23, 2018
Bioconjugation requires aseptic manufacturing and containment for cytotoxic payloads.
Oct 19, 2018
BioPharm International
To achieve a more dynamic marketplace, FDA is issuing guidance documents and targeted advisories to support R&D on complex generics and combination products.
Oct 18, 2018
By BioPharm International Editors
Novartis plans to acquire Endocyte, a biopharmaceutical company, to accelerate the development of innovative radioligand technology for treating cancer.
native1_300x100
lorem ipsum